STANFORD — Stanford researchers have developed T-cells capable in a laboratory setting of resisting HIV, a breakthrough that could pave the way for a possible gene therapy which would be able to stop the virus that causes AIDS.

The discovery, reported in Tuesday’s issue of Molecular Therapy, suggests it could be possible to strength any cell that HIV attacks, making it impossible for the virus to infect any part of the immune system.

‘HIV is a very nefarious and devious virus that likes to mutate and escape all the roadblocks we put in its way. So what we’re trying to do is not just simply make one roadblock, but instead create several roadblocks,